Terms: = Uterine cancer AND PAX8, ENSG00000125618, 7849 AND Prognosis
14 results:
1. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
2. Significance analysis of pax8 expression in endometrial carcinoma.
Hu S; Gan H; Yang F
Medicine (Baltimore); 2022 Oct; 101(42):e31159. PubMed ID: 36281161
[TBL] [Abstract] [Full Text] [Related]
3. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
4. pax8 plays an essential antiapoptotic role in uterine serous papillary cancer.
Fares B; Berger L; Bangiev-Girsh E; Kakun RR; Ghannam-Shahbari D; Tabach Y; Zohar Y; Gottlieb E; Perets R
Oncogene; 2021 Aug; 40(34):5275-5285. PubMed ID: 34244607
[TBL] [Abstract] [Full Text] [Related]
5. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
[TBL] [Abstract] [Full Text] [Related]
6. Molecularly Classified uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features.
Joehlin-Price A; Van Ziffle J; Hills NK; Ladwig N; Rabban JT; Garg K
Am J Surg Pathol; 2021 Mar; 45(3):421-429. PubMed ID: 33021522
[TBL] [Abstract] [Full Text] [Related]
7. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
8. Dedifferentiated carcinoma of the ovary. A case report.
Němejcová K; Rosmusová J; Bártů M; Matěj R; Dundr P
Cesk Patol; 2018; 54(1):33-36. PubMed ID: 29631410
[TBL] [Abstract] [Full Text] [Related]
9. [Significance and expression of pax8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
10. uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical Profiling of Endometrial Serous Carcinoma.
Chen W; Husain A; Nelson GS; Rambau PF; Liu S; Lee CH; Lee S; Duggan MA; Köbel M
Int J Gynecol Pathol; 2017 Mar; 36(2):128-139. PubMed ID: 27167671
[TBL] [Abstract] [Full Text] [Related]
12. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract] [Full Text] [Related]
13. miR-21-3p is a positive regulator of L1CAM in several human carcinomas.
Doberstein K; Bretz NP; Schirmer U; Fiegl H; Blaheta R; Breunig C; Müller-Holzner E; Reimer D; Zeimet AG; Altevogt P
Cancer Lett; 2014 Nov; 354(2):455-66. PubMed ID: 25149066
[TBL] [Abstract] [Full Text] [Related]
14. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract] [Full Text] [Related]
